Welcome to our dedicated page for Pharmadrug news (Ticker: LMLLF), a resource for investors and traders seeking the latest updates and insights on Pharmadrug stock.
PharmaDrug Inc. reports developments tied to its specialty pharmaceutical focus on research, development and commercialization of controlled substances, natural medicines, psychedelics and previously approved or naturally derived drugs. Company news includes updates on pharmaceutical drug development, including cepharanthine-focused activity, as well as clinical and regulatory disclosures, operating and financial results, and material agreements.
Recurring corporate updates also cover capital-structure actions such as convertible debentures and warrants, governance changes, shareholder matters and strategic-review disclosures affecting the company's assets, research programs and financing profile.
Summary not available.
Summary not available.
Summary not available.
Summary not available.